Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
0(0%)
Results Posted
10%(1 trials)
Terminated
3(20%)

Phase Distribution

Ph early_phase_1
1
7%
Ph phase_1
5
33%
Ph phase_2
7
47%
Ph phase_3
2
13%

Phase Distribution

6

Early Stage

7

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
1(6.7%)
Phase 1Safety & dosage
5(33.3%)
Phase 2Efficacy & side effects
7(46.7%)
Phase 3Large-scale testing
2(13.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

10 of 14 finished

Non-Completion Rate

28.6%

4 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(10)
Terminated(4)
Other(1)

Detailed Status

Completed10
Terminated3
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
76.9%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (6.7%)
Phase 15 (33.3%)
Phase 27 (46.7%)
Phase 32 (13.3%)

Trials by Status

terminated320%
unknown17%
withdrawn17%
completed1067%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT01957709Early Phase 1

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Terminated
NCT00003414Phase 3

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Completed
NCT00006113Phase 2

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Terminated
NCT00024271Phase 2

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Unknown
NCT00070187Phase 2

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Completed
NCT00002475Phase 2

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Completed
NCT00002637Phase 1

Biological Therapy in Treating Patients With Prostate Cancer

Completed
NCT00059878Phase 2

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

Completed
NCT00004016Phase 1

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Completed
NCT00008203Phase 3

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

Completed
NCT00002796Phase 1

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

Terminated
NCT00004032Phase 1

Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

Completed
NCT00002761Phase 1

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Withdrawn
NCT00616720Phase 2

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Completed
NCT00002505Phase 2

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

Completed

All 15 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
15